Glioblastoma cell growth is suppressed by disruption of fibroblast growth factor pathway signaling

Watcharin Loilome, Avadhut D. Joshi, Colette M.J. ap Rhys, Sara Piccirillo, Vescovi L. Angelo, Gary L. Gallia, Gregory J. Riggins

Research output: Contribution to journalArticlepeer-review

53 Scopus citations

Abstract

The Fibroblast Growth Factor (FGF) signaling pathway is reported to stimulate glioblastoma (GBM) growth. In this work we evaluated the effect of FGF2, FGF receptor (FGFR), and small molecule inhibition on GBM cells grown in traditional media, or cultured directly in stem-cell media. These lines each expressed the FGFR1, FGFR3 and FGFR4 receptors. Addition of FGF2 ligand showed significant growth stimulation in 8 of 10 cell lines. Disruption of FGF signaling by a neutralizing FGF2 monoclonal antibody and FGFR1 suppression by RNA interference both partially inhibited cell proliferation. Growth inhibition was temporally correlated with a reduction in MAPK signaling. A receptor tyrosine kinase inhibitor with known FGFR/VEGFR activity, PD173074, showed reproducible growth inhibition. Possible mechanisms of growth suppression by PD173074 were implicated by reduced phosphorylation of AKT and MAPK, known oncogenic signal transducers. Subsequent reduction in the cyclin D1, cyclin D2 and CDK4 cell cycle regulators was also observed. Our results indicate that FGF signaling pathway inhibition as a monotherapy will slow, but not arrest growth of glioblastoma cells.

Original languageEnglish (US)
Pages (from-to)359-366
Number of pages8
JournalJournal of Neuro-Oncology
Volume94
Issue number3
DOIs
StatePublished - 2009

Keywords

  • Fibroblast growth factor signaling pathway
  • GBM stem-like cell
  • Glioblastoma

ASJC Scopus subject areas

  • Oncology
  • Neurology
  • Clinical Neurology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Glioblastoma cell growth is suppressed by disruption of fibroblast growth factor pathway signaling'. Together they form a unique fingerprint.

Cite this